Cermak Samantha, Meng Qinglei, Peng Kevin, Baldwin Simone, Mejías-Aponte Carlos A, Yang Yihong, Lu Hanbing
Neuroimaging Research Branch, Histology Core, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Baltimore, MD, 21224, USA.
Neuroimaging Research Branch, Histology Core, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Baltimore, MD, 21224, USA.
J Neurosci Methods. 2020 Jun 1;339:108709. doi: 10.1016/j.jneumeth.2020.108709. Epub 2020 Apr 5.
Transcranial magnetic stimulation (TMS) is an emerging neuromodulation tool. However, preclinical models of TMS are limited.
To develop a method for performing TMS in awake rats and to characterize neuronal response to TMS by mapping glucose uptake following TMS administration.
A headpost was implanted into rat skull serving as a refence to guide TMS target. Motor threshold measurement was used as the metric to assess the consistency in TMS delivery across animals and across sessions. Using a fluorescent glucose analogue (2-NBDG) as a marker of neuronal activity, we mapped glucose uptake in response to TMS of the rat motor cortex.
The average motor threshold (n = 41) was 34.6 ± 6.3 % of maximum stimulator output (MSO). The variability of motor threshold across animals was similar to what has been reported in human studies. Furthermore, there was no significant difference in motor threshold measured across 3 separate days. Enhancement in fluorescent signals were TMS dose (power)-dependent, which centered around the motor cortex, covering an area medial-laterally 2 mm, rostral-caudally 4 mm at 55 % MSO, and 3 mm at 35 % MSO. The count of total cells with significant fluorescent signal was: 107 ± 23 (55 % MSO), 73 ± 11 (35 % MSO) and 42 ± 11 (sham, 5% MSO).
Our method allows for consistent motor threshold assessment for longitudinal studies. Notably, cells with fluorescent signal enhancement were consistently aggregated in deep cortical layers, with minimal enhancement in superficial layers COMPARISONS WITH EXISTING METHOD(S): To our knowledge, this is the first study of focal TMS in awake rodents.
经颅磁刺激(TMS)是一种新兴的神经调节工具。然而,TMS的临床前模型有限。
开发一种在清醒大鼠中进行TMS的方法,并通过绘制TMS给药后葡萄糖摄取情况来表征神经元对TMS的反应。
将一个头柱植入大鼠颅骨作为引导TMS靶点的参考。运动阈值测量用作评估不同动物和不同实验阶段TMS递送一致性的指标。使用荧光葡萄糖类似物(2-NBDG)作为神经元活动的标志物,我们绘制了大鼠运动皮层对TMS反应的葡萄糖摄取情况。
平均运动阈值(n = 41)为最大刺激器输出(MSO)的34.6±6.3%。不同动物之间运动阈值的变异性与人类研究中报道的相似。此外,在3个不同日期测量的运动阈值没有显著差异。荧光信号增强呈TMS剂量(功率)依赖性,其集中在运动皮层周围,在55% MSO时,内侧-外侧覆盖2 mm区域,前后覆盖4 mm区域,在35% MSO时覆盖3 mm区域。具有显著荧光信号的总细胞数为:107±23(55% MSO)、73±11(35% MSO)和42±11(假刺激,5% MSO)。
我们的方法允许对纵向研究进行一致的运动阈值评估。值得注意的是,荧光信号增强的细胞始终聚集在皮质深层,浅层增强最小。与现有方法的比较:据我们所知,这是首次对清醒啮齿动物进行局灶性TMS研究。